FIND evaluations of SARS-CoV-2 assays
Following open calls for expressions of interest, FIND has been conducting independent evaluations of both molecular and immunoassays for SARS-CoV-2, in collaboration with multiple partner institutions (see partner map below). The call for partners to join the evaluations for antibody, antigen and molecular tests is now closed. New selection rounds may be announced by end of 2021. More information on the evaluation process and results for each type of test can be found via the links below. For questions relating to these evaluations, please contact our Emerging Threats team.
Our SARS-CoV-2 assay evaluation partners
Click on image to enlarge